Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FGF2 Promoter Hypermethylation and Implant Wound Healing Among Smokers and Diabetics

NCT01663298 is registered in ClinicalTrials.gov with University of North Carolina, Chapel Hill as lead sponsor.

NCT NCT01663298
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01663298 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FGF2 Promoter Hypermethylation and Implant Wound Healing Among Smokers and Diabetics
Lead sponsor
University of North Carolina, Chapel Hill
Phase
Observational
Overall status
Completed
Start date
August 31, 2010
Completion date
February 23, 2016
Enrollment
44 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, smoking